Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Phathom Pharmaceuticals (PHAT) Gross Profit: 2018-2024

Historic Gross Profit for Phathom Pharmaceuticals (PHAT) over the last 7 years, with Dec 2024 value amounting to $47.3 million.

  • Phathom Pharmaceuticals' Gross Profit rose 209.47% to $43.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $128.4 million, marking a year-over-year increase of 485.20%. This contributed to the annual value of $47.3 million for FY2024, which is 9080.39% up from last year.
  • Phathom Pharmaceuticals' Gross Profit amounted to $47.3 million in FY2024, which was up 9,080.39% from $515,000 recorded in FY2023.
  • Phathom Pharmaceuticals' 5-year Gross Profit high stood at $47.3 million for FY2024, and its period low was -$27.3 million during FY2022.
  • Over the past 3 years, Phathom Pharmaceuticals' median Gross Profit value was $515,000 (recorded in 2023), while the average stood at $6.8 million.
  • In the last 5 years, Phathom Pharmaceuticals' Gross Profit slumped by 302.25% in 2022 and then surged by 9,080.39% in 2024.
  • Over the past 5 years, Phathom Pharmaceuticals' Gross Profit (Yearly) stood at -$4.6 million in 2020, then tumbled by 48.18% to -$6.8 million in 2021, then slumped by 302.25% to -$27.3 million in 2022, then spiked by 101.89% to $515,000 in 2023, then soared by 9,080.39% to $47.3 million in 2024.